Total Amount Duration Role Grant Agency Project Title awarded (CAD) 75,000 01/2012 PI Alberta Innovates Development of a Business – – 06/2013 Health Solutions Proposal for a Alberta Centre for Personalized Diagnostics 1,500,000 01/2011 Co-I Novartis Developing an expert system for – 06/2012 Pharmaceuticals reading the molecular phenotype of biopsies 200,000 01/2010 PI Roche Organ The Integrin-TGF-beta-pathway in – 01/2012 Transplant Research Interstitial Fibrosis and Tubular Foundation Atrophy in human renal allografts (grant # 701904686) 10,000 01/2011 PI Organogenesis Inc. Histopathology of artificial skin – 01/2012 allografts. 50,000 04/2010 PI Astellas The Banff Working Groups – 05/2011 Pharmaceuticals, Canada 25,000 01/2010 PI University of Alberta Molecular Phenotyping of – 06/2011 Hospital Foundation in Heart Transplants Medical Research Competition 90,000 03/2008 Co-I Astellas Role of B cells and Plasma cells in – 03/2010 Pharmaceuticals the progression of interstitial fibrosis and tubular atrophy in renal allografts 25,000 01/2009 PI University of Alberta Mast Cells in Interstitial Fibrosis – 12/2009 Hospital Foundation and Tubular Atrophy of Renal Medical Research Allografts Competition 50,000 06/2006 - Co-I Deutsche Recruitment and activation of 10/2008 mesenchymal cells in renal (=German equivalent allografts of National Institutes of Health) 300,000 03/2005 - PI DFG Project Grant: Pathogenetic role of tissue 03/2007 DFG-ME 2097/3-1 transglutaminase in the development of chronic allograft nephropathy 150,000 06/2003 - PI Brauckmann Cardiac in situ microchimerism 06/2006 Wittenberg Heart after heart and bone marrow Foundation transplantation 60,000 01/2006 PI Dr. Werner Jackstaedt Differential and cell-specific gene – 12/2006 Kidney Foundation expression in the mouse model of acute renal failure
Total Amount awarded (CAD) Duration Role Grant Agency Project Title 75,000 01/2012 – 06/2013 PI Alberta Innovates – Health Solutions Development of a Business Proposal for a Alberta Centre for Personalized Diagnostics 1,500,000 01/2011 – 06/2012 Co-I Novartis Pharmaceuticals Developing an expert system for reading the molecular phenotype of biopsies 200,000 01/2010 – 01/2012 PI Roche Organ Transplant Research Foundation The Integrin-TGF-beta-pathway in Interstitial Fibrosis and Tubular Atrophy in human renal allografts (grant # 701904686) 10,000 01/2011 – 01/2012 PI Organogenesis Inc. Histopathology of artificial skin allografts. 50,000 04/2010 – 05/2011 PI Astellas Pharmaceuticals, Canada The Banff Working Groups 25,000 01/2010 – 06/2011 PI University of Alberta Hospital Foundation Medical Research Competition Molecular Phenotyping of in Heart Transplants 90,000 03/2008 – 03/2010 Co-I Astellas Pharmaceuticals Role of B cells and Plasma cells in the progression of interstitial fibrosis and tubular atrophy in renal allografts 25,000 01/2009 – 12/2009 PI University of Alberta Hospital Foundation Medical Research Competition Mast Cells in Interstitial Fibrosis and Tubular Atrophy of Renal Allografts 50,000 06/2006 - 10/2008 Co-I Deutsche (=German equivalent of National Institutes of Health) Recruitment and activation of mesenchymal cells in renal allografts 300,000 03/2005 - 03/2007 PI DFG Project Grant: DFG-ME 2097/3-1 Pathogenetic role of tissue transglutaminase in the development of chronic allograft nephropathy 150,000 06/2003 - 06/2006 PI Brauckmann Wittenberg Heart Foundation Cardiac in situ microchimerism after heart and bone marrow transplantation 60,000 01/2006 – 12/2006 PI Dr. Werner Jackstaedt Kidney Foundation Differential and cell-specific gene expression in the mouse model of acute renal failure
curriculum-vitaemengeloctober-2015.docx